MaxCyte, Inc. (MXCT.L)

GBp 206.0

(-3.74%)

Total Liabilities Summary of MaxCyte, Inc.

  • MaxCyte, Inc.'s latest annual total liabilities in 2023 was 36.1 Million USD , up 10.47% from previous year.
  • MaxCyte, Inc.'s latest quarterly total liabilities in 2024 Q2 was 30.23 Million USD , down -4.23% from previous quarter.
  • MaxCyte, Inc. reported annual total liabilities of 32.68 Million USD in 2022, up 54.01% from previous year.
  • MaxCyte, Inc. reported annual total liabilities of 21.22 Million USD in 2021, up 14.38% from previous year.
  • MaxCyte, Inc. reported quarterly total liabilities of 31.57 Million USD for 2024 Q1, down -12.56% from previous quarter.
  • MaxCyte, Inc. reported quarterly total liabilities of 33.72 Million USD for 2023 Q1, up 3.18% from previous quarter.

Annual Total Liabilities Chart of MaxCyte, Inc. (2023 - 2012)

Historical Annual Total Liabilities of MaxCyte, Inc. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 36.1 Million USD 10.47%
2022 32.68 Million USD 54.01%
2021 21.22 Million USD 14.38%
2020 18.55 Million USD 13.25%
2019 16.38 Million USD 36.69%
2018 11.98 Million USD 1.57%
2017 11.8 Million USD 7.39%
2016 10.98 Million USD 15.87%
2015 9.48 Million USD 19.31%
2014 7.94 Million USD 96.37%
2013 4.04 Million USD 17.92%
2012 3.43 Million USD 0.0%

Peer Total Liabilities Comparison of MaxCyte, Inc.

Name Total Liabilities Total Liabilities Difference